Cashin and Graf: long-term intraperitoneal 5-fluorouracil is superior to adjuvant FOLFOX in a randomized trial.
作者信息
Sugarbaker Paul H, Van der Speeten Kurt
机构信息
MedStar Washington Hospital Center, Washington, DC, USA.
Department of Surgery, Hospital Oost-Limburg, Genk, Belgium.
出版信息
J Gastrointest Oncol. 2021 Apr;12(Suppl 1):S136. doi: 10.21037/jgo-2020-16.
Abstract
摘要
相似文献
1
Cashin and Graf: long-term intraperitoneal 5-fluorouracil is superior to adjuvant FOLFOX in a randomized trial.卡欣和格拉夫：在一项随机试验中，长期腹腔内注射5-氟尿嘧啶优于辅助性FOLFOX方案。
J Gastrointest Oncol. 2021 Apr;12(Suppl 1):S136. doi: 10.21037/jgo-2020-16.
2
Oxaliplatin, fluorouracil, and leucovorin versus fluorouracil and leucovorin as adjuvant chemotherapy for locally advanced rectal cancer after preoperative chemoradiotherapy (ADORE): an open-label, multicentre, phase 2, randomised controlled trial.奥沙利铂、氟尿嘧啶和亚叶酸钙与氟尿嘧啶和亚叶酸钙作为术前放化疗后局部进展期直肠癌的辅助化疗（ADORE）：一项开放标签、多中心、2 期、随机对照临床试验。
Lancet Oncol. 2014 Oct;15(11):1245-53. doi: 10.1016/S1470-2045(14)70377-8. Epub 2014 Sep 4.
3
Oxaliplatin-Based Adjuvant Chemotherapy for Rectal Cancer After Preoperative Chemoradiotherapy (ADORE): Long-Term Results of a Randomized Controlled Trial.奥沙利铂为基础的辅助化疗在术前放化疗后直肠癌（ADORE）：随机对照试验的长期结果。
J Clin Oncol. 2019 Nov 20;37(33):3111-3123. doi: 10.1200/JCO.19.00016. Epub 2019 Oct 8.
4
Upfront radical surgery with total mesorectal excision followed by adjuvant FOLFOX chemotherapy for locally advanced rectal cancer (TME-FOLFOX): an open-label, multicenter, phase II randomized controlled trial.局部进展期直肠癌行全直肠系膜切除术联合辅助 FOLFOX 化疗的 upfront 根治性手术（TME-FOLFOX）：一项开放标签、多中心、二期随机对照临床试验。
Trials. 2020 Apr 7;21(1):320. doi: 10.1186/s13063-020-04266-6.
5
Assessment of Duration and Effects of 3 vs 6 Months of Adjuvant Chemotherapy in High-Risk Stage II Colorectal Cancer: A Subgroup Analysis of the TOSCA Randomized Clinical Trial.高危 II 期结直肠癌辅助化疗 3 个月与 6 个月的持续时间和效果评估：TOSCA 随机临床试验的亚组分析。
JAMA Oncol. 2020 Apr 1;6(4):547-551. doi: 10.1001/jamaoncol.2019.6486.
6
Cost-effectiveness of adjuvant FOLFOX therapy for stage III colon cancer in Japan based on the MOSAIC trial.基于 MOSAIC 试验的日本 III 期结肠癌辅助 FOLFOX 治疗的成本效益。
Value Health. 2012 Mar-Apr;15(2):255-60. doi: 10.1016/j.jval.2011.10.006. Epub 2011 Dec 15.
7
Does neoadjuvant FOLFOX chemotherapy improve the prognosis of high-risk Stage II and III colon cancers? Three years' follow-up results of the PRODIGE 22 phase II randomized multicentre trial.新辅助 FOLFOX 化疗是否能改善高危 II 期和 III 期结肠癌的预后？PRODIGE 22 期随机多中心试验的 3 年随访结果。
Colorectal Dis. 2021 Jun;23(6):1357-1369. doi: 10.1111/codi.15585. Epub 2021 Mar 10.
8
Perioperative Systemic Therapy vs Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Alone for Resectable Colorectal Peritoneal Metastases: A Phase 2 Randomized Clinical Trial.可切除结直肠腹膜转移的围手术期全身治疗与单独细胞减灭术和腹腔热灌注化疗的比较：一项 2 期随机临床试验。
JAMA Surg. 2021 Aug 1;156(8):710-720. doi: 10.1001/jamasurg.2021.1642.
9
Role of Deficient DNA Mismatch Repair Status in Patients With Stage III Colon Cancer Treated With FOLFOX Adjuvant Chemotherapy: A Pooled Analysis From 2 Randomized Clinical Trials.III 期结肠癌患者接受 FOLFOX 辅助化疗时错配修复缺陷状态的作用：来自 2 项随机临床试验的汇总分析。
JAMA Oncol. 2018 Mar 1;4(3):379-383. doi: 10.1001/jamaoncol.2017.2899.
10
Real-world tolerance and outcomes of oxaliplatin-based adjuvant chemotherapy for stage III colon cancer-Does dose intensity matter?基于奥沙利铂的辅助化疗治疗 III 期结肠癌的真实世界耐受性和结局-剂量强度是否重要？
Asia Pac J Clin Oncol. 2024 Feb;20(1):63-70. doi: 10.1111/ajco.13965. Epub 2023 May 22.
本文引用的文献
1
Sequential postoperative intraperitoneal chemotherapy for colorectal cancer with peritoneal metastases: a narrative review.结直肠癌伴腹膜转移术后序贯腹腔内化疗：一项叙述性综述
J Gastrointest Oncol. 2021 Apr;12(Suppl 1):S131-S135. doi: 10.21037/jgo-20-137.
Zotero 插件